多元组件和皮拉提斯训练增加了帕金森病患者在行走和携带负载时的步行速度:单盲随机对照试验
Júlia de Faria1, Lucas Resende Sousa2, Ana Cláudia Pamplona Dorásio3
1School of Physical Education and Sport of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.
概括
马特皮拉提训练 (MPT) 和多元组件训练 (MCT) 都改善了帕金森病 (IwPD) 患者的步行速度. 通过调整速度和节奏,MPT还增强了步行稳定性.
科学领域:
- 神经学 神经学
- 物理疗法物理治疗
- 运动科学 运动科学
背景情况:
- 步态障碍是帕金森病 (IwPD) 患者残疾的主要原因.
- 身体炼干预措施对于管理IwPD至关重要,特别是改善步行表现.
- 评估不同炼计划的有效性对于优化康复策略至关重要.
研究的目的:
- 评估Mat Pilates训练 (MPT) 和多元件训练 (MCT) 对IwPD时空步态变量的影响.
- 在双重任务条件下评估步行表现,模拟现实生活场景,增加跌倒风险.
- 为了比较MPT与MCT在改善轻度至中度帕金森病患者的步态方面的有效性.
主要方法:
- 一个单盲随机对照试验,涉及34名轻度至中度IwPD患者 (Hoehn-Yahr阶段1-2).
- 参与者被分配到MPT或MCT组,进行60分钟的会议,每周三次,持续20周.
- 在双重任务步行场景中测量了时空步行变量,并增加了负载 (10%的体重),以提高生态有效性.
主要成果:
- 无论是MPT和MCT组,干预后的步行速度均显著改善.
- 在MPT组,节奏节奏显著降低.
- 而MCT组的脚步长度显著增加.
结论:
- 无论是Mat Pilates训练还是多元组件训练,都在负载行走条件下对帕金森病患者的步行速度产生了积极的影响.
- 马特 Pilates 训练导致速度和节奏的时空调整,可能提高步态稳定性.
- 多元组件训练改善了步伐长度,而MPT为步行稳定提供了在MCT组中没有观察到的明显好处.
相关概念视频
Parkinson's Disease: Treatment
302
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
302
Parkinson's Disease: Overview
606
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
606


